NovoCure
NVCR
NVCR
243 hedge funds and large institutions have $1.19B invested in NovoCure in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 84 increasing their positions, 79 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.69% less ownership
Funds ownership: 84.73% → 82.04% (-2.7%)
30% less capital invested
Capital invested by funds: $1.68B → $1.19B (-$496M)
Holders
243
Holding in Top 10
2
Calls
$20.4M
Puts
$4.49M
Top Buyers
| 1 | +$36.6M | |
| 2 | +$9.2M | |
| 3 | +$9.1M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.21M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$7.19M |
Top Sellers
| 1 | -$58.6M | |
| 2 | -$40.4M | |
| 3 | -$14.7M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$10.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.96M |
